Hangzhou Hongyou Pharmaceutical Technology Co., Ltd., established on 2019-05-06, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Natural science research and experimental development;Pharmaceutical commissioned production(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Drug Wholesale;Drug retail(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Zhejiang Huahai Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products. It also integrates and intermediates formulations such as Active Pharmaceutical Ingredients. Its products include Irbesartan and Hydrochlorothiazide Tablet, Paroxetine Hydrochloride Tablet and Irbesartan Tablet. The company was founded in 1989 and is headquartered in Zhejiang, China.

Jinan Tonglu Pharmaceutical Technology Development Co., Ltd., established on 2006-04-12, Business scope includes general items:Medical Research and Experimental Development;Engineering and Technology Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Chemical product sales(No licensed chemical products)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:pharmaceutical production;Import and export;Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Shanghai Beishu Biotechnology Co., Ltd., established on 2013-04-17, Business scope includes engaging in biotechnology,Photoelectric New Material Technology,Technology development in the field of chemical technology,technical consulting,Technical Services,technology transfer,Chemical products and raw materials(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),Class I medical device,Sales of Class II Medical Devices,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Xinjiang Huayu Sairui Pharmaceutical Research and Development Co., Ltd., established on 2009-07-08, Business scope includes licensed business items:none.General operating items:(National law,Except for projects that require special approval according to regulations):drug development.

Part of Shanghai Pharmaceuticals Holding Co., Ltd., Shanghai Sine Pharmaceutical Co. Ltd. is a Chinese company located in Shanghai. The firm manufactures and distributes pharmaceutical products. It was acquired by Shanghai Pharmaceuticals Holding Co., Ltd. from Shanghai Pharmaceutical (Group) Co., Ltd. on February 03, 2010 for $124.70 million.

Zhejiang Huahai Pharmaceutical Co., Ltd. Shanghai Branch, established on 2004-04-22, The scope of business includes import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Shanghai Kesheng Pharmaceutical Research and Development Co., Ltd., established on 2005-04-08, Business scope includes biological,Research and development of pharmaceutical products and technology transfer,Sales of pharmaceutical intermediates,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Wante Pharmaceutical (Hainan) Co., Ltd., established on 2004-03-09, Business scope includes licensed projects:pharmaceutical production;Drug Wholesale(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Chemical product sales(No licensed chemical products)(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Overseas Pharmaceuticals, Ltd. (OPL) is founded in Dec.2011 by Dr. Gilbert (Xiaoguang) Wen. The headquarter is located in Guangzhou and the two subsidiary companies are based in Taizhou, China and San Diego, USA, respectively. OPL is a specialty pharmaceutical company with a focus on development of proprietary controlled-release platform technologies and on application of these technologies in developing second/next generation NDA products which are safer, more efficacious and more patient compliance comparing with the previous marketed products as a mean to extend the life of current marketed products

Biophore is a developer and manufacturer of pharmaceutical products for the generic industry.

Shanghai Yishengyuan Pharmaceutical Co., Ltd., established on 2001-06-26, Business range includes tablet,Granules,pill(honey pill),oral solution(Contains antineoplastic drugs),aerosol,spray,API,Production of traditional Chinese medicine extraction workshop. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Gritpharma engaged in the industrialization of new pharmaceutical products, technology transfer, technical assistance, and the creation of new drugs. Complete business skills in areas like clinical research.

Suzhou Yellow River Pharmaceutical Co., Ltd., established on 2002-07-05, Business scope includes production,Selling Sulfasalazine(Crude),Doxepin Hydrochloride(Crude),Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export). (Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Zhejiang Aitewei Biotechnology Co., Ltd., established on 2022-02-28, Business scope includes general items:Medical Research and Experimental Development;R&D and application of cell technology;Engineering and Technology Research and Experimental Development;Natural science research and experimental development;Sales of Class I Medical Devices;Wholesale of protective equipment for medical staff;Retailing of protective equipment for healthcare workers;Sales of Class II Medical Devices;Sales of hygiene products and single-use medical products;Wholesale medical masks;Medical Mask Retail(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Inspection and testing service;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Beijing Dezhong Wanquan Pharmaceutical Technology Development Co., Ltd., established on 1998-12-11, Business scope includes technology transfer,Technical Services;Research,Development of new drug preparations,raw material,Excipients and Biopharmaceuticals.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Nexchem Pharmaceutical Co., Ltd. produces active pharmaceutical ingredients for global markets. Its products encompass azithromycin dihydrate, clarithromycin, roxithromycin, meropenem, fenofibrate, benserazide hydrochloride, and levosulpiride. The company was founded in December 2002 and is headquartered in Jinhua, China.

Huanggang Yinhe Adi Pharmaceutical Co., Ltd., established on 2006-06-10, Business scope includes licensed projects:pharmaceutical production;Drug Wholesale;Drug retail;Drug import and export;Import and export of toxic chemicals;fertilizer production;Veterinary drug production;Import and export;Hazardous Chemical Production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Chemical product production(No licensed chemical products);Chemical product sales(No licensed chemical products);Sales of new organic active materials;fertilizer sales;[It is forbidden to invest in the steaming of traditional Chinese medicine decoction pieces,saute,broil,The application of calcining and other processing technologies and the production of secret prescription products of Chinese patent medicines],(The above projects do not involve special management measures for foreign investment access)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Founded in 2002, Hefei Lifang Pharmaceutical Co., Ltd. is an innovative pharmaceutical enterprise integrating the research and development, production and sales of pharmaceutical preparations and raw materials, and the wholesale and retail of pharmaceuticals and medical devices. It has formed a whole industry for the pharmaceutical industry and pharmaceutical business. Chain coverage, the main industrial products involve cardiovascular drugs, digestive system drugs, external skin drugs, endocrine system drugs, and other fields. Lifang Pharmaceutical owns 4 industrial enterprises, 1 pharmaceutical commercial enterprise, and 1 pharmaceutical retail chain enterprise, and has been successfully listed on the SME board of the Shenzhen Stock Exchange on December 15, 2020.